Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy | NeoGenomics Laboratories

Publication date

Mon, 04/27/2020 - 12:00

Category

Tumor mutational burden

Year

Subtitle

Presented at AACR 2020

File

AACR_2020-Poster-3170-final.pdf (1.04 MB)

Division